TOBRADEX, eye drop suspension bottle, 5 ml
Active ingredients: Dexamethasone, Tobramycin
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop suspensionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TOBRADEX, collyre en suspension
- Pharmaceutical form
- collyre en suspension
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène de 5 ml avec embout compte-gouttes
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jan 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66302120CIP73442997CIP133400934429972Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DEXAMÉTHASONEcollyre | 0,10 g · 100 ml | SA |
| TOBRAMYCINEcollyre | 0,30 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.